Replies to post #174179 on Biotech Values

[DewDiligence]

ENTA at Leerink: Phase-1 trials of ABT-493 and ABT-530 are completed, and dose-ranging phase-1b monotherapy trials are underway for each drug. Data from phase-1 to be released at unspecified venue in 2014.